We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA Targets Specific Homeopathic Drug Categories in Final Guidance
FDA Targets Specific Homeopathic Drug Categories in Final Guidance
The FDA plans to prioritize its enforcement and regulatory actions against specific homeopathic drug categories that pose a significant risk to public health, the agency said in a final guidance.